Status:

NOT_YET_RECRUITING

Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females

Lead Sponsor:

Universiti Putra Malaysia

Conditions:

Psychosis

Metabolic Syndrome

Eligibility:

FEMALE

18-65 years

Phase:

PHASE4

Brief Summary

Patients with psychiatric disorders, including depression, anxiety, and schizophrenia, often require antipsychotic medications for symptom management. However, metabolic changes, especially weight gai...

Detailed Description

This study aims to investigate the effectiveness of different combinations of aripiprazole with atypical antipsychotics in preventing or minimizing weight gain in patients with various psychiatric con...

Eligibility Criteria

Inclusion

  • Females aged 18-65 years diagnosed with a mental health condition necessitating antipsychotic treatment.
  • Diagnosis of Schizophrenia or Schizoaffective Disorder
  • On stable doses of atypical antipsychotics, either Olanzapine, Clozapine, or Risperidone for at least 1 month
  • Willingness to comply with the study protocol.

Exclusion

  • Pregnancy or lactation.
  • Severe medical conditions impacting weight or metabolism.
  • Previous intolerance or contraindications to Aripiprazole.
  • Non-compliant with prescribed medications
  • Mental Retardation
  • Participant with an eating disorder
  • Participants with serious suicidal thoughts, or who pose a serious risk of harm to self or to others.
  • Diagnosis of Hyper or Hypothyroidism; Evidence of thyroid dysfunction as evidenced by serum thyroid function tests (i.e Thyroid Stimulating Hormone and -Free Thyroxine (fT4) levels \> 10 % above or below the limits of the normal range Use of any medication for weight loss within the past one month to the study entry
  • Clinically significant abnormalities in physical examinations, ECG or lab assessments

Key Trial Info

Start Date :

September 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 10 2025

Estimated Enrollment :

600 Patients enrolled

Trial Details

Trial ID

NCT06590298

Start Date

September 15 2024

End Date

April 10 2025

Last Update

September 19 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.